Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Atul Mehta

Showing results (111-120 of 150) with videos related to

Pageof 15
Sort By:
American Journal of Hematology|March 25, 2015
Velaglucerase alfa (VPRIV) enzyme replacement therapy in patients with Gaucher disease: Long-term data from phase III clinical trialsDerralynn A Hughes, Derlis E Gonzalez, Elena A Lukina, et al.
Chest|February 3, 2018
Radiation Exposure in the Medical ICU: Predictors and CharacteristicsSudhir Krishnan, Ajit Moghekar, Abhijit Duggal, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|July 12, 2002
A novel treatment approach for low grade lymphoproliferative disorders using PKC412 (CGP41251), an inhibitor of protein kinase CAndres Virchis, Kanagasabai Ganeshaguru, Steve Hart, et al.
Human Mutation|March 19, 2005
Thirty-four novel mutations of the GLA gene in 121 patients with Fabry diseaseEllen Schäfer, Karin Baron, Urs Widmer, et al.
The Annals of Thoracic Surgery|November 5, 2018
Patterns of Recurrence and Overall Survival in Incidental Lung Cancer in Explanted LungsUsman Ahmad, Ali H Hakim, Andrew Tang, et al.
British Journal of Haematology|November 25, 2020
DT-PACE/ESHAP chemotherapy regimens as salvage therapy for multiple myeloma prior to autologous stem cell transplantationLouise Ainley, Selina J Chavda, Nicholas Counsell, et al.
Plos One|August 2, 2017
Retrospective study of long-term outcomes of enzyme replacement therapy in Fabry disease: Analysis of prognostic factorsMaarten Arends, Marieke Biegstraaten, Derralynn A Hughes, et al.
Kidney International|April 21, 2005
Anemia is a new complication in Fabry disease: data from the Fabry Outcome SurveyJulia Kleinert, François Dehout, Andreas Schwarting, et al.
American Journal of Hypertension|August 1, 2006
Prevalence of uncontrolled hypertension in patients with Fabry diseaseJulia Kleinert, François Dehout, Andreas Schwarting, et al.
Journal of Inherited Metabolic Disease|February 22, 2012
The cognitive profile of type 1 Gaucher disease patientsMarieke Biegstraaten, Keith A Wesnes, Cécile Luzy, et al.
Pageof 15

Showing results (111-120 of 150) with videos related to

Sort By:
Pageof 15
American Journal of Hematology|March 25, 2015
Velaglucerase alfa (VPRIV) enzyme replacement therapy in patients with Gaucher disease: Long-term data from phase III clinical trialsDerralynn A Hughes, Derlis E Gonzalez, Elena A Lukina, et al.
Chest|February 3, 2018
Radiation Exposure in the Medical ICU: Predictors and CharacteristicsSudhir Krishnan, Ajit Moghekar, Abhijit Duggal, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|July 12, 2002
A novel treatment approach for low grade lymphoproliferative disorders using PKC412 (CGP41251), an inhibitor of protein kinase CAndres Virchis, Kanagasabai Ganeshaguru, Steve Hart, et al.
Human Mutation|March 19, 2005
Thirty-four novel mutations of the GLA gene in 121 patients with Fabry diseaseEllen Schäfer, Karin Baron, Urs Widmer, et al.
The Annals of Thoracic Surgery|November 5, 2018
Patterns of Recurrence and Overall Survival in Incidental Lung Cancer in Explanted LungsUsman Ahmad, Ali H Hakim, Andrew Tang, et al.
British Journal of Haematology|November 25, 2020
DT-PACE/ESHAP chemotherapy regimens as salvage therapy for multiple myeloma prior to autologous stem cell transplantationLouise Ainley, Selina J Chavda, Nicholas Counsell, et al.
Plos One|August 2, 2017
Retrospective study of long-term outcomes of enzyme replacement therapy in Fabry disease: Analysis of prognostic factorsMaarten Arends, Marieke Biegstraaten, Derralynn A Hughes, et al.
Kidney International|April 21, 2005
Anemia is a new complication in Fabry disease: data from the Fabry Outcome SurveyJulia Kleinert, François Dehout, Andreas Schwarting, et al.
American Journal of Hypertension|August 1, 2006
Prevalence of uncontrolled hypertension in patients with Fabry diseaseJulia Kleinert, François Dehout, Andreas Schwarting, et al.
Journal of Inherited Metabolic Disease|February 22, 2012
The cognitive profile of type 1 Gaucher disease patientsMarieke Biegstraaten, Keith A Wesnes, Cécile Luzy, et al.
Pageof 15